SEC Filings for Cannabics Pharmaceuticals Inc (CNBX)

$ 0.2435   0.006 (+2.53%) Volume: 107.74k 3:46 PM EDT 2-Jul-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)204/17/2020
8-KCurrent report pursuant to Section 13 or 15(d)404/17/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)2304/13/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)1901/14/2020
10-KAnnual report pursuant to Section 13 or 15(d)7311/29/2019
8-KCurrent report pursuant to Section 13 or 15(d)411/07/2019
8-KCurrent report pursuant to Section 13 or 15(d)311/08/2019
8-KCurrent report pursuant to Section 13 or 15(d)510/11/2019
8-KCurrent report pursuant to Section 13 or 15(d)410/07/2019
8-KCurrent report pursuant to Section 13 or 15(d)410/03/2019
8-KCurrent report pursuant to Section 13 or 15(d)507/23/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)2407/15/2019
8-KCurrent report pursuant to Section 13 or 15(d)406/25/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)2104/15/2019
SC 13GStatement of acquisition of beneficial ownership by individuals503/27/2019
<<
First
<
Prev
123456789101112131415